NCT05902169 Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM Status RECRUITING Phase PHASE3
NCT05900921 Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT05900206 Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer Status RECRUITING Phase PHASE2
NCT05891080 Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial Status NOT_YET_RECRUITING Phase PHASE2
NCT05889390 Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05883852 EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer Status RECRUITING Phase PHASE3
NCT05872412 Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer Status UNKNOWN Phase PHASE2
NCT05870319 A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05867251 Study of AVZO-021 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05834348 A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway. Status COMPLETED Phase N/A
NCT05832827 First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis) Status RECRUITING Phase PHASE2
NCT05821088 Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05819892 Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer Status RECRUITING Phase PHASE1
NCT05816252 A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05815160 Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy Status TERMINATED Phase PHASE1
NCT05809895 Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer Status WITHDRAWN Phase PHASE2
NCT05807542 Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC Status COMPLETED Phase PHASE2
NCT05806515 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation Status RECRUITING Phase PHASE2
NCT05800587 Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer Status RECRUITING Phase PHASE2